Patrick McIlvenny
Comptroller/Controller/Auditor bei HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
Aktive Positionen von Patrick McIlvenny
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Comptroller/Controller/Auditor | 11.11.2022 | - |
| Corporate Officer/Principal | 05.05.2022 | 11.11.2022 |
Karriereverlauf von Patrick McIlvenny
Ausbildung von Patrick McIlvenny
| University of Ulster | Undergraduate Degree |
Statistik
International
| Irland | 2 |
| Vereinigtes Königreich | 2 |
Operativ
| Comptroller/Controller/Auditor | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
- Börse
- Insiders
- Patrick McIlvenny
- Erfahrung
